Organometallics
Article
dry dimethylformamide (15 mL) was added CuI (140 mg, 0.73
mmol). The mixture was heated at 80 °C for 20 h, diluted with EtOAc
(50 mL), and filtered through a pad of Celite. The filtrate was washed
with H2O, and the aqueous layer was extracted with EtOAc. The
combined organic extract was concentrated, and the residue was
purified by column chromatography on silica gel and eluted with
EtOAc/hexanes [1:100 (v/v)] to give compound 2 (2.7 g, 87%) as a
white solid: 1H NMR (400 MHz, CDCl3) δ 7.99 (d, J = 2.4 Hz, 1H),
7.83 (d, J = 8.4 Hz, 2H), 7.77 (d, J = 1.2 Hz, 1H), 7.72 (d, J = 8.4 Hz,
2H), 6.52 (t, J = 2.0 Hz, 1H). Anal. Calcd for C10H7F3N2: C, 56.61;
H, 3.33; N, 13.20. Found: C, 56.60; H, 3.32; N, 13.22.
(m, 6H), 6.35 (d, J = 1.2 Hz, 2H), 6.30 (t, J = 2.8 Hz, 2H); HRMS
calcd for C44H32F6IrN5O2P2 1031.156 ([M + H]+), found 1032.156.
Anal. Calcd for C44H32F6IrN5O2P2: C, 51.26; H, 3.13; N, 6.79.
Found: C, 51.21; H, 3.12; N, 6.80.
1
Ir2 (104 mg, 49% yield): yellow powder; H NMR (400 MHz,
CDCl3) δ 8.34 (s, 2H), 8.17 (d, J = 8.8 Hz, 2H), 7.77−7.82 (m, 4H),
7.45 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 7.6 Hz, 2H), 7.28−7.32 (m,
6H), 7.10−7.15 (m, 4H), 6.98 (t, J = 7.6 Hz, 2H), 6.83−6.89 (m,
4H), 6.64−6.70 (m, 6H), 6.54 (t, J = 7.2 Hz, 2H), 6.08 (d, J = 7.2 Hz,
2H); HRMS calcd for C50H38IrN5O2P2 995.213 ([M + H]+), found
996.225. Anal. Calcd for C50H38IrN5O2P2: C, 60.35; H, 3.85; N, 7.04.
Found: C, 60.28; H, 3.82; N, 7.11.
2-Phenyl-2H-indazole (h-1-pidz, 2b). A solution of phenyl-
amine (1.0 g, 10.7 mmol) and 2-nitrobenzaldehyde (1.6 g, 10.7
mmol) in EtOH (20 mL) was refluxed for 8 h. After removal of most
of the solvent, the yellow solid was collected by filtration to afforded
compound 1b, which was used in the next step without further
purification. Compound 1b (1.2 g, 5.3 mmol) was dissolved in
P(OEt)3 (15 mL) and heated at 110 °C for 10 h. The solvent was
removed, and the resulting residue was purified by column
chromatography on silica gel and eluted with EtOAc/hexanes [1:50
1
Ir3 (104 mg, 66% yield): orange powder; H NMR (400 MHz,
CDCl3) δ 8.29 (2s, 2H), 8.10 (d, J = 8.8 Hz, 2H), 7.78−7.82 (m,
4H), 7.44 (d, J = 7.2 Hz, 2H), 7.32−7.39 (m, 8H), 7.08−7.13 (m,
4H), 6.97 (t, J = 7.6 Hz, 2H), 6.88 (t, J = 7.6 Hz, 2H), 6.57−6.69 (m,
8H), 5.68−5.71 (m, 2H); HRMS calcd for C50H36F2IrN5O2P2
1031.194 ([M + H]+), found 1032.223. Anal. Calcd for
C50H36F2IrN5O2P2: C, 58.25; H, 3.52; N, 6.79. Found: C, 58.22; H,
3.48; N, 6.83.
1
1
Ir4 (138 mg, 61% yield): orange powder; H NMR (400 MHz,
(v/v)] to give compound 2b (760 mg, 86%) as a white solid: H
CDCl3) δ 8.30 (s, 2H), 8.09 (d, J = 8.8 Hz, 2H), 7.77−7.82 (m, 4H),
7.45 (d, J = 8.4 Hz, 2H), 7.31−7.39 (m, 8H), 7.07−7.12 (m, 4H),
6.99 (t, J = 8.0 Hz, 2H), 6.86−6.90 (m, 2H), 6.65−6.77 (m, 8H),
5.82 (d, J = 1.2 Hz, 2H); HRMS calcd for C52H36F6IrN5O2P2
1131.188 ([M + H]+), found 1164.186 ([MS + H + MeOH]+).
Anal. Calcd for C52H36F6IrN5O2P2: C, 55.22; H, 3.21; N, 6.19.
Found: C, 55.17; H, 3.32; N, 6.25.
NMR (400 MHz, CDCl3) δ 8.40 (s, 1H), 7.90 (d, J = 7.6 Hz, 2H),
7.81 (d, J = 8.8 Hz, 1H), 7.70 (d, J = 8.8 Hz, 1H), 7.52 (t, J = 7.6 Hz,
2H), 7.31−7.41 (m, 2H), 7.12 (dd, J1 = 7.2 Hz, J2 = 8.0 Hz, 1H).
Anal. Calcd for C13H10N2: C, 80.39; H, 5.19; N, 14.42. Found: C,
80.40; H, 5.18; N, 14.43.
Compounds 2c and 2d (2e−2g) were obtained in good to
excellent yields by following the procedure described for 2b (2a).
2-(4-Fluorophenyl)-2H-indazole (f-1-pidz, 2c). White solid:
1
Ir5 (128 mg, 57% yield): yellow powder; H NMR (400 MHz,
1
CDCl3) δ 8.17 (s, 2H), 8.12 (d, J = 8.8 Hz, 2H), 7.77−7.83 (m, 4H),
7.68 (d, J = 7.2 Hz, 2H), 7.48−7.53 (m, 4H), 7.28−7.40 (m, 10H),
7.21−7.25 (m, 2H), 6.92 (t, J = 7.2 Hz, 2H), 6.76 (t, J = 7.6 Hz, 2H),
6.65−6.69 (m, 4H), 6.54 (t, J = 7.2 Hz, 2H), 6.13 (dd, J1 = 1.6 Hz, J2
= 7.2 Hz, 2H); HRMS calcd for C50H38IrN5O2P2 995.213 ([M +
H]+), found 996.219. Anal. Calcd for C50H38IrN5O2P2: C, 60.35; H,
3.85; N, 7.04. Found: C, 60.40; H, 3.79; N, 7.07.
750 mg (83% yield); H NMR (400 MHz, CDCl3) δ 8.37 (s, 1H),
7.84−7.86 (m, 2H), 7.78 (d, J = 8.8 Hz, 1H), 7.69 (d, J = 8.4 Hz,
1H), 7.31−7.35 (m, 1H), 7.19−7.23 (m, 2H), 7.12 (dd, J1 = 6.8 Hz,
J2 = 8.0 Hz, 1H). Anal. Calcd for C13H10FN2: C, 73.57; H, 4.27; N,
13.20. Found: C, 73.55; H, 4.26; N, 13.23.
2-[4-(Trifluoromethyl)phenyl]-2H-indazole (cf3-1-pidz, 2d).
1
White solid: 820 mg (89% yield); H NMR (400 MHz, CDCl3) δ
1
Ir6 (146 mg, 63% yield): yellow powder; H NMR (400 MHz,
8.45 (s, 1H), 8.05 (d, J = 8.8 Hz, 2H), 7.77−7.79 (m, 3H), 7.70 (d, J
= 8.4 Hz, 1H), 7.33−7.37 (m, 1H), 7.11−7.15 (m, 1H). Anal. Calcd
for C13H10F3N2: C, 64.12; H, 3.46; N, 10.68. Found: C, 64.14; H,
3.45; N, 10.69.
1-Phenyl-1H-indazole (h-7-pidz, 2e). White solid: 980 mg
(92% yield); 1H NMR (400 MHz, CDCl3) δ 8.23 (s, 1H), 7.74−7.83
(m, 4H), 7.55 (t, J = 7.6 Hz, 2H), 7.42−7.46 (m, 2H), 7.35−7.39 (m,
1H), 7.22−7.25 (m, 2H). Anal. Calcd for C13H10N2: C, 80.39; H,
5.19; N, 14.42. Found: C, 80.41; H, 5.19; N, 14.41.
CDCl3) δ 8.13 (s, 2H), 8.05 (d, J = 8.8 Hz, 2H), 7.76−7.81 (m, 4H),
7.62 (dd, J1 = 4.8 Hz, J2 = 8.4 Hz, 2H), 7.48−7.54 (m, 4H), 7.32−
7.38 (m, 6H), 7.27−7.29 (m, 2H), 7.22−7.25 (m, 4H), 6.76 (t, J =
7.6 Hz, 2H), 6.62−6.69 (m, 6H), 5.78 (dd, J1 = 2.8 Hz, J2 = 9.6 Hz,
2H); HRMS calcd for C50H36F2IrN5O2P2 1031.194 ([M + H]+),
found 1032.201. Anal. Calcd for C50H36F2IrN5O2P2: C, 58.25; H,
3.52; N, 6.79. Found: C, 58.20; H, 3.47; N, 6.86.
1
Ir7 (113 mg, 49% yield): yellow powder; H NMR (400 MHz,
CDCl3) δ 8.19 (s, 2H), 8.11 (d, J = 8.4 Hz, 2H), 7.72−7.81 (m, 6H),
7.57 (t, J = 8.0 Hz, 2H), 7.51 (d, J = 8.0 Hz, 2H), 7.34−7.41 (m, 6H),
7.28 (t, J = 7.6 Hz, 2H), 7.21−7.25 (m, 6H), 6.76 (t, J = 7.2 Hz, 2H),
6.62−6.67 (m, 4H), 6.36 (d, J = 1.6 Hz, 2H); HRMS calcd for
C52H36F6IrN5O2P2 1131.188 ([M + H]+), found 1132.196. Anal.
Calcd for C52H36F6IrN5O2P2: C, 55.22; H, 3.21; N, 6.19. Found: C,
55.27; H, 3.20; N, 6.21.
1-(4-Fluorophenyl)-1H-indazole (f-7-pidz, 2f). White solid:
1.05 g (90% yield); 1H NMR (400 MHz, CDCl3) δ 8.10 (s, 1H), 7.71
(d, J = 8.0 Hz, 1H), 7.56−7.60 (m, 3H), 7.31−7.35 (m, 1H), 7.11−
7.16 (m, 3H). Anal. Calcd for C13H10FN2: C, 73.57; H, 4.27; N,
13.20. Found: C, 73.57; H, 4.28; N, 13.21.
1-[4-(Trifluoromethyl)phenyl]-1H-indazole (cf3-7-pidz, 2g).
White solid: 1.14 g (88% yield); 1H NMR (400 MHz, CDCl3) δ 8.25
(s, 1H), 7.91 (d, J = 8.0 Hz, 2H), 7.82 (t, J = 8.4 Hz, 4H), 7.49 (t, J =
8.0 Hz, 1H), 7.28−7.32 (m, 1H). Anal. Calcd for C13H10F3N2: C,
64.12; H, 3.46; N, 10.68. Found: C, 64.13; H, 3.47; N, 10.70.
General Synthetic Procedure for Ir(III) Complexes Ir1−Ir7.
The cyclometalated Ir(III) dichloro-bridged dimers, [(C^N)2Ir(μ-
Cl)]2, were synthesized by IrCl3 hydrate with 2.2 equiv of 2a−2g in a
3:1 mixture of 2-ethoxyethanol and deionized water according to a
method similar to that reported by Nonoyama.34 Then Ir(III)
complexes Ir1−Ir7 were prepared by the reaction of Ir(III) dichloro-
bridged dimers with 2.2 equiv of Ktpip in 2-ethoxyethanol at 120 °C.
After the reaction was completed, the reaction mixture was diluted
with water and extracted multiple times with dichloromethane. The
combined organic phase was concentrated, and the residue was
purified by column chromatography to provide the crude product,
which was further purified by vacuum sublimation.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
1
OLED fabrication and measurement, H NMR spectra
and mass spectrometry of main ligands 2a−2g and
iridium complexes Ir1−Ir7, emission spectra of iridium-
(III) complexes Ir1−Ir7 in degassed CH2Cl2 solutions
at 77 K, PL spectra of Ir3 and Ir6 in solution and solid
state, EL spectra of D3 and D6, crystallographic data
and selected bonds and angles of complexes Ir2−Ir7,
and frontier orbital energy and electron density
distributions of complexes Ir1−Ir7 (PDF)
1
Ir1 (124 mg, 53% yield): yellow powder; H NMR (400 MHz,
CDCl3) δ 7.88 (d, J = 2.8 Hz, 2H), 7.67−7.72 (m, 4H), 7.61 (d, J =
2.0 Hz, 2H), 7.27−7.36 (m, 10H), 7.15−7.23 (m, 4H), 7.06−7.11
H
Organometallics XXXX, XXX, XXX−XXX